Originally from Peru, he's worked all around the world, he's an advisor, a Med-tech CEO, a father of two, medical education strategist, mentor, and he's only in his mid-thirties 

It is fair to say that this week's guest has a few stories to share

Jhonatan Bringas is a Founding Partner (CEO) of Lapsi Health.

Lapsi Health is developing Digital Therapy (DTX) solutions for the next generation. Their goal is to have a pediatric population that has chronic conditions under control.

Separately, Jhonatan is a medical Education Ambassador for Medscape - Working together with a great team to develop the strategy to enhance online Medical Education worldwide.

In this week's episode, he shares his story about travelling across the world, learning multiple languages, and adapting to the nuances involved when working in different countries.

This week we discuss Patient Recruitment strategy and how Facebook is one of the most effective means of reaching a wide audience.

Ross talks us through targeted advertising and how it works. ‘Is Big Brother watching you?’

Ross has also written a book on the subject so if you’re running a Clinical trial and you need to find an edge that will attract willing patients this is a must-listen for you.

Series 3 Ep.15 Robert Nauman Managing Director at JBS Ventures.

Assisting leaders and entrepreneurs execute their vision in Life Sciences and Health IT.

That’s what this weeks guest is all about.

He first got into the pharma industry after his father suggested it was a good place to earn some money.

20 Years’s on, and he’s still active. Having spent time with some of the industry giants such as GSK, he is now using his ability to solve key business issues and create organizational change that maximizes revenue and minimize cost.

For Rachel Jones failure was not an option when she lost her mother and was made redundant in a matter of days.

A single mum of two children, Rachel boxed up her emotions and landed her dream project working on Patient engagement. Through her experience, she then went on to Co-found Swii.ch Health a successful boutique agency specialising in digital, behavioural change and patient Engagement.

Rachel shares her story and tips that have helped her to be successful and happy in her career.

Series 3 Ep.13 – Stuart McCully Founder of Phoenix RWR and Co-Founder of Real World Research.

Stuart opens up about his darkest moments, his successes and his failures in Entrepreneurship. We also discuss the topic of Mental health and why there's such a stigma around talking about certain topics.

Phoenix-RWR is a consulting firm that specializes in providing regulatory compliance solutions and regulatory intelligence for real-world research studies, such as non-interventional studies.

Series 3, Episode 12 Panel show special!

This week we have several returning guests for a special edition panel show where we discuss ‘What it takes to Change an Industry’

Our panel of experts include Scott Stout CEO at Medvector - Finance Expert.

Scott’s previous appearance on the show - https://youtu.be/dC5g8_f42pc

Ted Barduson COO at Medvector – Healthcare and physicians practice Expert.

Craig Lipset Founder at Clinical Innovation Partner – Decentralized Trials & Innovation Expert.

Craig’s previous appearance on the show - https://youtu.be/4Oz0KZkc5-k

Adam Walker – Healthcare & Biometrics Expert.

Adam’s previous appearance on the show - https://youtu.be/g-88Wd6miEk

All of our guests form part of the MedVector Clinical Trials team that is streamlining the Clinical Research Industry.

We discuss the following topics:

What does it take to change an industry?

New people, new companies, acceptance of established companies innovative ideas.

The pandemic and its impact on:

- The explosion, acceptance of telemedicine.

- The impact on the DCT marketplace.

- The awareness of clinical trials and how patient-centricity is linked to the guidance of physicians.

- The financial impact on doctors individual and practice revenues and profits.

What is Medvector? And what is it not?

And WHY RIGHT NOW?

With over 20 years of experience in Clinical operations, Mike shares his story and how he transitioned to a new job at the height of the pandemic.

Mike is a keen advocate for decentralized trials and has several predictions about the Clinical development field to share.

This week we speak to Jo Bhakdi Founder and CEO of Quantgene.

Jo and the team at Quantgene are about to launch Serenity, the worlds first medical solution to protect against multiple cancers through early detection and prevention.

Jo combines the perfect blend of economics and science to become a real disrupter in the industry.

In today’s episode, we cover

Who is Jo Bhakdi and what is his background?

What does Quantgene do?

Jo’s vision is what he calls “10 in 10” to extend the healthy human lifespan by a decade within the next decade.

How Quantgene helped the film industry get back on its feet by providing on-site coronavirus testing and results within a 24hrs window.

Answers to our quick-fire questions.

This week we speak to Vidya Maharaj, Vice president of Clinical Operations and Development at Regenerative Outcomes.

Not only does she have an extremely successful career in pharmaceuticals which has seen her rapidly climb through the ranks. Vidya is also executive Chef at one of Miami's hottest beachfront restaurants. 

Find out how she juggles two extremely successful careers and everything else in between.

Radically improving the detection, diagnosis and treatment of women’s health-related disease.

Elizabeth Cormier-May and the team Mammogen are integrating data, science and the lived experiences from patients that they serve into the ongoing product development efforts related to their flagship breast cancer program.

Mammogen is a female-led biotechnology company focused on meaningfully improving the detection, diagnosis and treatment of women's health-related diseases, and creating an end-to-never-end community for women around the world.

 

Mammogen is centred around its proprietary genTRU™ liquid biopsy platform. The company's flagship genTRU breast™ program leverages novel messenger RNA (mRNA) technology to non-invasively detect and diagnose breast cancer.

Mammogen's core technology is a non-invasive screening solution intended for all women, but particularly for the under-40 population who aren't eligible for annual mammography and the 55+ population who are only recommended for mammography every other year.